Completed

NCT Number: NCT00222547

Deworming and Enhanced Vitamin A Every 6 Month in Rural Indian Children Aged 1-6

Randomisation of 72 large rural areas ("blocks") into a 2 x 2 trial of six- monthly treatment of all village children aged 1-5 with albendazole(400mg), vitamin A (200000 iu), both or neither. The placebo group get no trial treatment at all and do not receive physical placebos.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Village Children

Age range

1 year–6 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Shally Awasthi

Lucknow, Uttar Pradesh, UP226 003, India

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

InclusionCriteria:

Area of residence

Exclusion criteria

NONE

Treatment and study plan

Vitamin A

Drug

Albendazole

Drug

Primary outcomes

childhood mortality rate at age 1-6

Secondary outcomes

fecal egg counts, plasma retinal, growth, sign of Vitamin A deficiency

Sponsors and collaborators

Lead sponsor

University of Oxford

Other

Collaborators

United States Agency for International Development (USAID)

Registry information

Official study title

Deworming and Enhanced Vitamin A Supplementation DEVTA Project

Important dates

Study start: 1999
Study completion: 2005
First posted: Sep 22, 2005
Registry last updated: Oct 28, 2005

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.